Monitoring Clinical Trials Based on Predictive Probability of Significance

DOI10.2307/2532056MaRDI QIDQ3201537zbMATH OpenOpenAlexWikidataFDO

Authors Sung C. Choi, Patricia A. Pepple

Publication date 1989

Published in Biometrics (Search for Journal in Brave)

Full work available at URL https://doi.org/10.2307/2532056

zbMATH Keywords

clinical trialcomparing the means of two normal populationscurtailed procedureinterim analysispredictive probability

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• STATISTICAL METHODS FOR MONITORING CLINICAL TRIALS
• Statistical monitoring of clinical trials. A unified approach.
• Efficacy and toxicity monitoring via Bayesian predictive probabilities in phase II clinical trials
• Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials

Cited in

(16)

• Two useful distributions for Bayesian predicitve procedures under normal models
• Assessing a vector of clinical observations
• Monitoring Accumulating Data in a Clinical Trial
• Index and prevision of satisfaction in exponential models for clinical trials
• On the curtailment of sampling
• USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS
• Bayesian interim analysis of lifetime data
• Interim analyses and early termination of clinical trials
• CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OFH₀
• Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
• A new expectation identity and its application in the calculations of predictive powers assuming normality
• Bayesian sequential analysis of clinical trials feedback
• Bayesian adaptive determination of the sample size required to assure acceptably low adverse event risk
• DOD-SSR: an adaptive seamless phase II/III design with dose optimization decision and sample size re-estimation
• Predictive probability methods for interim monitoring in clinical trials with longitudinal outcomes
• Improving the effectiveness of sample size re-estimation: an operating characteristic focused, hybrid frequentist-Bayesian approach

This page was built for publication: Monitoring Clinical Trials Based on Predictive Probability of Significance

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201537)